Best Practices for Conducting and Reporting Pharmacoepidemiologic Safety Studies Using Electronic Healthcare Data Sets
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 14, 2013
January 31, 2025
5a792e07-313c-4b6e-a098-39e274850db6
Related Documents
S6 (R1) Addendum: Preclinical Safety Evaluation of Biotechnology - Derived Pharmaceuticals
Guidance DocumentMay 15, 2012Center for Drug Evaluation and Research
Clinical Pharmacogenomics: Premarket Evaluation in Early-Phase Clinical Studies and Recommendations for Labeling
Guidance DocumentJanuary 28, 2013Center for Drug Evaluation and Research
Q11 Development and Manufacture of Drug Substances
Guidance DocumentNovember 20, 2012Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.